Clinical trials recruiting for Locally Advanced Rectal Cancer (LARC)
3
Recruiting trials
0
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 2Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CAPOX chemotherapy | 1 |
| Serplulimab immunotherapy | 1 |
| Short-course radiotherapy | 1 |
| Targeted therapy with bevacizumab | 1 |
| Tislelizumab | 1 |
| Total neoadjuvant therapy (TNT) | 1 |
Self-screener
Recruiting trials
- A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer
- Application and Exploration of Personalized ctDNA-MRD Detection Technology in Predicting the Efficacy of Neoadjuvant Therapy for Rectal Cancer
- Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.
Related conditions
Trials recruiting for Locally Advanced Rectal Cancer (LARC) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Locally Advanced Rectal Cancer (LARC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.